Declared Dividend • Jun 01
Dividend of €0.70 announced Shareholders will receive a dividend of €0.70. Ex-date: 3rd June 2026 Payment date: 5th June 2026 Dividend yield will be 3.3%, which is higher than the industry average of 3.0%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months. However, the dividend is covered by cash flows (60% cash payout ratio). The dividend has not increased over the past 3 years but payments have been stable during that time. 공고 • May 28
Tessenderlo Group NV announces Annual dividend, payable on June 05, 2026 Tessenderlo Group NV announced Annual dividend of EUR 0.1479 per share payable on June 05, 2026, ex-date on June 03, 2026 and record date on June 04, 2026. Reported Earnings • Mar 30
Full year 2025 earnings released: €1.34 loss per share (vs €0.70 profit in FY 2024) Full year 2025 results: €1.34 loss per share (down from €0.70 profit in FY 2024). Revenue: €2.76b (up 4.4% from FY 2024). Net loss: €81.1m (down 290% from profit in FY 2024). Revenue is forecast to grow 4.2% p.a. on average during the next 3 years, compared to a 10% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 94 percentage points per year, which is a significant difference in performance. Buy Or Sell Opportunity • Mar 26
Now 27% undervalued after recent price drop Over the last 90 days, the stock has fallen 15% to €22.00. The fair value is estimated to be €30.08, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company became loss making. Buy Or Sell Opportunity • Mar 02
Now 21% undervalued after recent price drop Over the last 90 days, the stock has fallen 4.2% to €26.35. The fair value is estimated to be €33.18, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company became loss making. Buy Or Sell Opportunity • Jan 08
Now 21% undervalued The stock has been flat over the last 90 days, currently trading at €25.63. The fair value is estimated to be €32.56, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company became loss making. Buy Or Sell Opportunity • Dec 09
Now 23% undervalued The stock has been flat over the last 90 days, currently trading at €25.43. The fair value is estimated to be €33.14, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company became loss making. Reported Earnings • Aug 25
First half 2025 earnings released: €0.16 loss per share (vs €0.97 profit in 1H 2024) First half 2025 results: €0.16 loss per share (down from €0.97 profit in 1H 2024). Revenue: €1.49b (up 7.1% from 1H 2024). Net loss: €9.50m (down 116% from profit in 1H 2024). Revenue is forecast to grow 4.3% p.a. on average during the next 3 years, compared to a 17% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 78 percentage points per year, which is a significant difference in performance. Declared Dividend • May 26
Dividend of €0.53 announced Shareholders will receive a dividend of €0.53. Ex-date: 4th June 2025 Payment date: 6th June 2025 Dividend yield will be 2.0%, which is lower than the industry average of 3.0%. Sustainability & Growth Dividend is not covered by earnings (108% earnings payout ratio). However, it is well covered by cash flows (30% cash payout ratio). The dividend has not increased over the past 2 years but payments have been stable during that time. The company's earnings per share (EPS) would need to grow by 20% to bring the payout ratio under control. EPS is expected to grow by 113% over the next 3 years, which is sufficient to bring the dividend into a sustainable range. 공고 • May 22
Tessenderlo Group NV announces Annual dividend, payable on June 06, 2025 Tessenderlo Group NV announced Annual dividend of EUR 0.5250 per share payable on June 06, 2025, ex-date on June 04, 2025 and record date on June 05, 2025. Buy Or Sell Opportunity • Apr 06
Now 21% undervalued Over the last 90 days, the stock has risen 19% to €23.30. The fair value is estimated to be €29.39, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.1% over the last 3 years. Earnings per share has declined by 56%. For the next 3 years, revenue is forecast to grow by 4.3% per annum. Earnings are also forecast to grow by 23% per annum over the same time period. 공고 • Mar 27
Tessenderlo Group NV, Annual General Meeting, May 13, 2025 Tessenderlo Group NV, Annual General Meeting, May 13, 2025. New Risk • Mar 27
New minor risk - Dividend sustainability The dividend is not well covered by earnings. Payout ratio: 107% Dividend yield: 3.0% This is considered a minor risk. Companies that pay out too much of their earnings are at risk of having to reduce or cut their dividend in future. If earnings growth slows or earnings fall, then there may not be enough earnings to maintain the same dividend. Or in extreme cases, companies may opt to dig into capital reserves or take on debt to maintain the dividend. However, this risk is mitigated by the fact the dividend is covered by cash flows. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by earnings (107% payout ratio). Profit margins are more than 30% lower than last year (1.6% net profit margin). Reported Earnings • Mar 26
Full year 2024 earnings released: EPS: €0.70 (vs €1.74 in FY 2023) Full year 2024 results: EPS: €0.70 (down from €1.74 in FY 2023). Revenue: €2.65b (down 9.6% from FY 2023). Net income: €42.8m (down 61% from FY 2023). Profit margin: 1.6% (down from 3.7% in FY 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 4.3% p.a. on average during the next 3 years, compared to a 4.2% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has fallen by 56% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings. 공고 • Mar 26
Tessenderlo Group NV to Report First Half, 2025 Results on Aug 21, 2025 Tessenderlo Group NV announced that they will report first half, 2025 results on Aug 21, 2025 Reported Earnings • Aug 25
First half 2024 earnings released: EPS: €0.97 (vs €1.27 in 1H 2023) First half 2024 results: EPS: €0.97 (down from €1.27 in 1H 2023). Revenue: €1.39b (down 15% from 1H 2023). Net income: €60.4m (down 25% from 1H 2023). Profit margin: 4.3% (down from 4.9% in 1H 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 3.6% p.a. on average during the next 3 years, compared to a 5.7% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has fallen by 27% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings. 공고 • Aug 21
Tessenderlo Group NV to Report Fiscal Year 2024 Results on Mar 26, 2025 Tessenderlo Group NV announced that they will report fiscal year 2024 results on Mar 26, 2025 Board Change • Apr 11
Less than half of directors are independent Following the recent departure of a director, there are only 4 independent directors on the board. The company's board is composed of: 4 independent directors. 5 non-independent directors. Independent Non-Executive Director Ann Vereecke was the last independent director to join the board, commencing their role in 2023. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Mar 28
Full year 2023 earnings released: EPS: €1.74 (vs €5.27 in FY 2022) Full year 2023 results: EPS: €1.74 (down from €5.27 in FY 2022). Revenue: €2.93b (up 13% from FY 2022). Net income: €109.5m (down 52% from FY 2022). Profit margin: 3.7% (down from 8.8% in FY 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 2.2% p.a. on average during the next 3 years, compared to a 4.6% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has remained flat but the company’s share price has fallen by 14% per year, which means it is significantly lagging earnings. 공고 • Jan 09
Tessenderlo Group NV to Report First Half, 2024 Results on Aug 21, 2024 Tessenderlo Group NV announced that they will report first half, 2024 results on Aug 21, 2024 Reported Earnings • Aug 25
First half 2023 earnings released: EPS: €1.27 (vs €3.80 in 1H 2022) First half 2023 results: EPS: €1.27 (down from €3.80 in 1H 2022). Revenue: €1.63b (up 21% from 1H 2022). Net income: €80.4m (down 51% from 1H 2022). Profit margin: 4.9% (down from 12% in 1H 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 4.5% p.a. on average during the next 3 years, compared to a 4.9% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings. Upcoming Dividend • May 24
Upcoming dividend of €0.53 per share at 2.5% yield Eligible shareholders must have bought the stock before 31 May 2023. Payment date: 02 June 2023. Trailing yield: 2.5%. Lower than top quartile of British dividend payers (5.8%). In line with average of industry peers (2.4%). Reported Earnings • Mar 24
Full year 2022 earnings released: EPS: €5.26 (vs €4.37 in FY 2021) Full year 2022 results: EPS: €5.26 (up from €4.37 in FY 2021). Revenue: €2.59b (up 24% from FY 2021). Net income: €226.9m (up 21% from FY 2021). Profit margin: 8.8% (down from 9.0% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth. 공고 • Dec 20
Tessenderlo Group NV to Report First Half, 2023 Results on Aug 24, 2023 Tessenderlo Group NV announced that they will report first half, 2023 results on Aug 24, 2023 공고 • Oct 27
Tessenderlo Group NV to Report Fiscal Year 2022 Results on Mar 23, 2023 Tessenderlo Group NV announced that they will report fiscal year 2022 results on Mar 23, 2023 Reported Earnings • Aug 25
First half 2022 earnings released: EPS: €3.80 (vs €2.26 in 1H 2021) First half 2022 results: EPS: €3.80 (up from €2.26 in 1H 2021). Revenue: €1.34b (up 31% from 1H 2021). Net income: €163.6m (up 68% from 1H 2021). Profit margin: 12% (up from 9.5% in 1H 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is expected to shrink by 13% compared to a 21% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 34% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth. Reported Earnings • Mar 27
Full year 2020 earnings released: EPS €2.30 (vs €2.23 in FY 2019) The company reported a decent full year result with improved earnings and profit margins, although revenues were flat. Full year 2020 results: Revenue: €1.74b (flat on FY 2019). Net income: €99.1m (up 3.1% from FY 2019). Profit margin: 5.7% (up from 5.5% in FY 2019). Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth. Is New 90 Day High Low • Feb 25
New 90-day high: €37.28 The company is up 16% from its price of €32.00 on 27 November 2020. The British market is up 7.0% over the last 90 days, indicating the company outperformed over that time. However, its price trend is similar to the Chemicals industry, which is also up 16% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €137 per share. Is New 90 Day High Low • Jan 13
New 90-day high: €34.95 The company is up 13% from its price of €30.85 on 15 October 2020. The British market is up 15% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Chemicals industry, which is up 10.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €135 per share. Is New 90 Day High Low • Sep 19
New 90-day high: €34.80 The company is up 26% from its price of €27.70 on 19 June 2020. The British market is down 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 16% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €115 per share.